DK455486A - AIDS VACCINES AND IMMUNAL ANALYSIS - Google Patents

AIDS VACCINES AND IMMUNAL ANALYSIS Download PDF

Info

Publication number: DK455486A
Authority: DK; Denmark
Prior art keywords: aids vaccines; immunal; analysis; immunal analysis; vaccines
Prior art date: 1985-09-25

Application number

DK455486A

Other languages

Danish (da)

Other versions

DK455486D0 (en

Inventor

Shiu-Lok Hu

Anthony F Purchio

Linda Madisen

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-25

Filing date

1986-09-24

Publication date

1987-03-26

1986-09-24 Application filed by Oncogen filed Critical Oncogen

1986-09-24 Publication of DK455486D0 publication Critical patent/DK455486D0/en

1987-03-26 Publication of DK455486A publication Critical patent/DK455486A/en

Links

208000030507 AIDS Diseases 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK455486A 1985-09-25 1986-09-24 AIDS VACCINES AND IMMUNAL ANALYSIS DK455486A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US77990985A	1985-09-25	1985-09-25
US84298486A	1986-03-27	1986-03-27
US90521786A	1986-09-09	1986-09-09

Publications (2)

Publication Number	Publication Date
DK455486D0 DK455486D0 (en)	1986-09-24
DK455486A true DK455486A (en)	1987-03-26

Family

ID=27419757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK455486A DK455486A (en)	1985-09-25	1986-09-24	AIDS VACCINES AND IMMUNAL ANALYSIS

Country Status (22)

Country	Link
CN (1)	CN1020752C (en)
AT (1)	ATA256786A (en)
CH (1)	CH676247A5 (en)
DE (1)	DE3690508T1 (en)
DK (1)	DK455486A (en)
ES (2)	ES2002490A6 (en)
FI (1)	FI863848A (en)
FR (1)	FR2587720A2 (en)
GB (1)	GB2181435B (en)
GR (1)	GR862412B (en)
HU (1)	HU205780B (en)
IE (1)	IE59314B1 (en)
IL (1)	IL80073A (en)
IT (1)	IT1195829B (en)
MY (1)	MY103182A (en)
NL (1)	NL8602422A (en)
NO (1)	NO863803L (en)
NZ (1)	NZ217645A (en)
PT (1)	PT83434B (en)
SE (4)	SE8604007L (en)
WO (1)	WO1987002038A1 (en)
YU (1)	YU46753B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES8706824A1 (en) *	1985-04-08	1987-07-01	Genetic Systems Corp	EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
US4734362A (en) *	1986-02-03	1988-03-29	Cambridge Bioscience Corporation	Process for purifying recombinant proteins, and products thereof
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
US4983387A (en) *	1986-05-19	1991-01-08	Viral Technologies Inc.	HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
ES2056054T3 (en) *	1986-09-19	1994-10-01	Oncogen	USE OF ACTIVATED T-LYMPHOCYTES TO PREPARE A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AIDS.
IE872748L (en) *	1986-10-16	1988-04-16	Arjomari Europ	Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
JPS63258575A (en) *	1986-12-15	1988-10-26	レプリゲン　コーポレーション	Recombinant hiv envelope protein produced in insect cell
EP0283327B1 (en) *	1987-01-16	1997-06-25	Institut Pasteur	Peptides with the immunological properties of HIV-2
FR2610632B1 (en) *	1987-02-11	1990-12-21	Pasteur Institut	CHARACTERISTIC PEPTIDES OF HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN OF THESE VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
US5681713A (en) *	1987-05-08	1997-10-28	Smithkline Beecham Corporation	Expression of heterologous proteins in Drosophila cells
GB8714802D0 (en) *	1987-06-24	1987-07-29	Proteus Biotech Ltd	Synthetic polypeptides
DE10399031I1 (en) *	1987-08-28	2004-01-29	Health Research Inc	Recombinant viruses.
FR2620030B1 (en) *	1987-09-07	1990-03-23	Transgene Sa	VECTOR FOR THE EXPRESSION OF PROTEINS OF HIV-2 VIRUS, A CAUSAL AGENT FOR AIDS, CELL CULTURE INFECTED OR TRANSFORMED THROUGH THIS VECTOR, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
IL89118A0 (en) *	1988-02-03	1989-08-15	Microgenesys Inc	Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
US5763160A (en) *	1988-02-12	1998-06-09	United Biomedical, Inc.	Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
ES2059823T3 (en) *	1988-05-06	1994-11-16	Ferropas Ag	METHODS AND SYSTEMS FOR PRODUCING HIV ANTIGENS.
US5043262A (en) *	1988-05-12	1991-08-27	Dana Farber Cancer Institute	Protein, sequences containing the VPU gene therefore, vectors, methods of preparation and use
AP129A (en) *	1988-06-03	1991-04-17	Smithkline Biologicals S A	Expression of retrovirus gag protein eukaryotic cells
US5614404A (en) *	1988-06-10	1997-03-25	Theriod Biologics, Incorporated	Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) *	1988-06-10	1998-05-05	Therion Biologics Corporation	Self-assembled, defective, non-self-propagating lentivirus particles
US5631154A (en) *	1988-06-10	1997-05-20	Therion Biologics, Incorporated	Self assembled, defective, non-self-propagating lentivirus particles
WO1989012095A1 (en) *	1988-06-10	1989-12-14	Applied Biotechnology, Inc.	A method of evaluating recombinant vaccines against immunodeficiency virus
US5665577A (en) *	1989-02-06	1997-09-09	Dana-Farber Cancer Institute	Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
DE69031735T2 (en) *	1989-04-18	1998-03-12	Applied Biotechnology Inc	GENERATION OF HYBRID GENES AND PROTEINS BY RECOMBINATION BY VIRUS
ES2198400T3 (en) *	1989-06-01	2004-02-01	Applied Biotechnology, Inc.	VECTOR CODIFYING NON-SELF-PROPAGING, DEFECTIVE, SELF-ASSEMBLED VIRAL PARTICLES.
GB8923123D0 (en) *	1989-10-13	1989-11-29	Connaught Lab	A vaccine for human immunodeficiency virus
US5981276A (en) *	1990-06-20	1999-11-09	Dana-Farber Cancer Institute	Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
US5840312A (en) *	1991-05-02	1998-11-24	Institut Pasteur	Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
FR2676068B1 (en) *	1991-05-02	1994-11-04	Pasteur Institut	IMMUNOGENIC RECOMBINANT STRAINS OF B. ANTHRACIS - IMMUNOGENIC COMPOSITIONS CONTAINING THEM.
EP1136562A3 (en) *	1991-11-08	2003-06-25	PHARMACIA & UPJOHN COMPANY	Feline leukemia virus vaccines
DE4405810A1 (en)	1994-02-23	1995-08-24	Behringwerke Ag	Peptides derived from a retrovirus from the HIV group and their use
AU5259796A (en)	1995-02-10	1996-08-27	Worcester Foundation For Biomedical Research, Inc.	Delivery of exogenous compounds
US6013506A (en) *	1995-06-05	2000-01-11	Wardley; Richard C.	Feline leukemia virus vaccines
ES2143570T3 (en) *	1995-09-06	2000-05-16	Schablonentechnik Kufstein Ag	PROCEDURE FOR THE MANUFACTURE OF A SCREENPRINT TEMPLATE.
US5741492A (en) *	1996-01-23	1998-04-21	St. Jude Children's Research Hospital	Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6723558B1 (en)	1996-01-23	2004-04-20	St. Jude Children's Research Hospital	Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en)	2001-12-19	2008-05-06	Nektar Therapeutics	Pulmonary delivery of aminoglycosides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3485810T2 (en) *	1983-05-27	1992-12-10	Texas A & M University Syst	METHOD FOR PRODUCING A RECOMBINANT BACULOVIRUS EXPRESSION VECTOR.
US4662514A (en) *	1983-11-01	1987-05-05	Charleswater Products, Inc.	Electrically conductive polymeric tubes for static sensitive electronic devices
US9328391B1 (en) *	1984-08-22	2016-05-03	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Cloning and expression of HIV-1 DNA
IL76082A (en) *	1984-08-22	1991-07-18	Us Health	Molecular clones of the genome of htlv-iii and a process for the preparation thereof
EP0387914B1 (en) *	1984-10-18	1993-08-04	Institut Pasteur	Envelope antigens of the human immuno-deficiency virus, and their applications
GB8501473D0 (en) *	1985-01-21	1985-02-20	Pasteur Institut	Cloned dna sequences
CA1341423C (en) *	1984-10-31	2003-03-04	Paul A. Luciw	Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
ATE138100T1 (en) *	1984-12-24	1996-06-15	Genentech Inc	FUSIONS OF AIDS-RELATED POLYPEPTIDES
US4774175A (en) *	1985-03-01	1988-09-27	Centocor, Inc.	Immunochemical methods for the detection of antibody against HTLV-III
NZ215867A (en) *	1985-04-19	1989-10-27	Hoffmann La Roche	Aids envelope protein, dna vectors and method of production
FR2586427B1 (en) *	1985-08-20	1988-12-09	Pasteur Institut	NUCLEOTIDE AND POLYPEPTIDE SEQUENCES FROM VISNA VIRUS AND THEIR APPLICATION TO DIAGNOSTIC TESTS AND THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS

1986
- 1986-09-22 NZ NZ217645A patent/NZ217645A/en unknown
- 1986-09-22 GR GR862412A patent/GR862412B/en unknown
- 1986-09-23 SE SE8604007A patent/SE8604007L/en not_active Application Discontinuation
- 1986-09-23 IE IE252586A patent/IE59314B1/en not_active IP Right Cessation
- 1986-09-24 IT IT67730/86A patent/IT1195829B/en active
- 1986-09-24 GB GB8622987A patent/GB2181435B/en not_active Expired - Fee Related
- 1986-09-24 CH CH3821/86A patent/CH676247A5/fr not_active IP Right Cessation
- 1986-09-24 NO NO863803A patent/NO863803L/en unknown
- 1986-09-24 HU HU864072A patent/HU205780B/en not_active IP Right Cessation
- 1986-09-24 DK DK455486A patent/DK455486A/en not_active Application Discontinuation
- 1986-09-24 FI FI863848A patent/FI863848A/en not_active IP Right Cessation
- 1986-09-24 ES ES8602123A patent/ES2002490A6/en not_active Expired
- 1986-09-25 NL NL8602422A patent/NL8602422A/en not_active Application Discontinuation
- 1986-09-25 FR FR8613414A patent/FR2587720A2/en active Granted
- 1986-09-25 WO PCT/US1986/002002 patent/WO1987002038A1/en active Application Filing
- 1986-09-25 AT AT0256786A patent/ATA256786A/en unknown
- 1986-09-25 DE DE19863690508 patent/DE3690508T1/de not_active Withdrawn
- 1986-09-25 CN CN86106632A patent/CN1020752C/en not_active Expired - Fee Related
- 1986-09-25 PT PT83434A patent/PT83434B/en not_active IP Right Cessation
- 1986-09-25 YU YU165486A patent/YU46753B/en unknown
- 1986-12-31 IL IL8007386A patent/IL80073A/en not_active IP Right Cessation
1987
- 1987-09-29 MY MYPI87002188A patent/MY103182A/en unknown
1988
- 1988-05-13 ES ES8801494A patent/ES2006941A6/en not_active Expired
1991
- 1991-10-14 SE SE9102975A patent/SE9102975L/en not_active Application Discontinuation
- 1991-10-14 SE SE9102976A patent/SE9102976L/en not_active Application Discontinuation
- 1991-10-14 SE SE9102974A patent/SE9102974L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
FR2587720A2 (en)	1987-03-27
CH676247A5 (en)	1990-12-28
DE3690508T1 (en)	1988-06-23
YU165486A (en)	1989-08-31
NO863803L (en)	1987-03-26
ES2002490A6 (en)	1988-08-16
IL80073A (en)	1995-01-24
PT83434B (en)	1988-07-29
YU46753B (en)	1994-05-10
IL80073A0 (en)	1986-12-31
SE9102975D0 (en)	1991-10-14
GB2181435B (en)	1990-01-10
NZ217645A (en)	1991-11-26
PT83434A (en)	1986-10-01
ES2006941A6 (en)	1989-05-16
IT8667730A0 (en)	1986-09-24
IE862525L (en)	1987-03-25
NO863803D0 (en)	1986-09-24
SE8604007L (en)	1987-03-26
FR2587720B2 (en)	1995-02-10
FI863848A0 (en)	1986-09-24
SE9102974D0 (en)	1991-10-14
CN1020752C (en)	1993-05-19
NL8602422A (en)	1987-04-16
GB2181435A (en)	1987-04-23
HU205780B (en)	1992-06-29
GR862412B (en)	1987-01-23
IT1195829B (en)	1988-10-27
HUT42133A (en)	1987-06-29
MY103182A (en)	1993-05-29
SE9102974L (en)	1993-04-15
WO1987002038A1 (en)	1987-04-09
CN86106632A (en)	1987-05-13
ATA256786A (en)	1995-05-15
SE8604007D0 (en)	1986-09-23
SE9102976L (en)	1993-04-15
FI863848A (en)	1987-03-26
IE59314B1 (en)	1994-02-09
SE9102976D0 (en)	1991-10-14
SE9102975L (en)	1993-04-15
DK455486D0 (en)	1986-09-24
GB8622987D0 (en)	1986-10-29

Legal Events

Date	Code	Title	Description
1997-05-20	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK455486A (en)	1987-03-26	AIDS VACCINES AND IMMUNAL ANALYSIS
IT1205010B (en)	1989-03-10	TETRAIDRONAFTALIN-DERIVATIVES AND INDAN-DERIVATIVES
DK291186A (en)	1986-12-21	ANTIANAPHYLACTIC AND ANTIBRONCHOSPASTIC N-BENZHYDRYLDIAZACYCLOALKYLALKANANILIDES
DK543386D0 (en)	1986-11-13	THIENOOXAZINONES THEIR PREPARATION AND USE
DK62486D0 (en)	1986-02-07	VACCINE
DK62386D0 (en)	1986-02-07	VACCINE
DK139286A (en)	1986-10-03	INSIDE AND NAPHTHALENDER DERIVATIVES
DK436586D0 (en)	1986-09-11	CONDENSATOR Separator and separator
IT1188262B (en)	1988-01-07	SCI
ES551181A0 (en)	1987-01-01	QUANTITATIVE TOMODENSITOMETRY PROCEDURE AND DEVICE
KR870004977A (en)	1987-06-02	2,2'-Bi-1H-imidazole and its preparation method
FR2588259B1 (en)	1988-01-22	BIS-ACRIDINIQUES SINGLE-BRIDGE AND BIS-ACRIDINIQUES BIPONTES
IT1189880B (en)	1988-02-10	SIMPLE AND COMPLETE OUTPUT FOR DRAWERS
DK66087D0 (en)	1987-02-10	CARBOCYCLIC PURINUCLEOSIDE AND USE AND PREPARATION thereof
DK437986D0 (en)	1986-09-12	1-AMINO-3-PHENYL-PROPAN-2-OL-DERIVATIVES AND THEIR PREPARATION AND USE
DK567786A (en)	1986-11-26	NON-ADJUSTIVE VACCINE
DK363786D0 (en)	1986-07-30	HYDROQUINOLINES AND USE THEREOF
RO94063A2 (en)	1988-05-30	ANTIACNETIC AND ANTISEBOREIC PULSES
KR860014429U (en)	1986-12-08	Massage and automatic smearing
RO93833A2 (en)	1988-02-29	ANTIACNEIC AND ANTISEBOREIC SOLUTION
IT1208712B (en)	1989-07-10	SCREWDRIVER AND UNSCREWER
KR860014554U (en)	1986-12-08	Forceps and screwdriver
BR6501751U (en)	1987-06-09	REMOVABLE SHACK
BR8601118A (en)	1987-09-08	IMANTATOR AND DEIMANTATOR
SE8505427D0 (en)	1985-11-18	METSPO AND CASSPO